Niclosig 500 mg Signature Pharmaceuticals Ltd.
| Features | |
| Active substance | Niclosamide |
| Also known as | Bayluscide, Nicloside |
| Blood pressure | No significant effect on blood pressure |
| Chemical name | 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide |
| Dosage (medical) | Typically 2 grams initially, followed by 1 gram twice a day for a total of 7 days |
| Dosage (sports) | Not applicable |
| Effects | Effective against a wide range of intestinal parasites |
| Formula | C13H8Cl2N2O4 |
| Half-life | 3 to 4 days in humans |
| Hepatotoxicity | Low risk of hepatotoxicity |
| Lab Test | Detection in biological samples via chromatography and mass spectrometry |
| Main action | Inhibits mitochondrial oxidative phosphorylation in susceptible organisms |
| Side effects | Nausea, vomiting, abdominal pain |
| Storage conditions | Store at room temperature, away from moisture and light |
| Strength | 500mg |
| Substance class | Anthelmintic |
| Trade name | Niclocide, Fenasal |
| Use in sports | Not typically used in sports |
| Water Retention | No significant water retention |
| Manufacturer | Signature Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |